4 completed. 4 Phase 3.
By phase and status
Follow Rotavirus Vaccines: new trials by email Literature Review of Rotavirus Vaccines trials Research Report on Rotavirus Vaccines
Trials (filtered) newest first · largest first
All 4 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years. The pentavalent rotavirus vaccine (live attenuated oral, freeze-dried), Placebo - Rotavirus Infections, Rotavirus Vaccines | Phase 3 | Completed | 40 | 2018-06-25 | 2021-09-08 |
This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine Rotarix, Pediarix, Hiberix - Rotavirus Infection, Rotavirus Vaccines | Phase 3 | Completed | 1280 | 2017-09-14 | 2020-12-29 |
Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks HRV PCV-free liquid vaccine, Rotarix - Infections, Rotavirus, Rotavirus Vaccines | Phase 3 | Completed | 1612 | 2016-10-27 | 2020-07-21 |
Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants Rotarix, Placebo - Infections, Rotavirus, Rotavirus Vaccines | Phase 3 | Completed | 765 | 2007-06-19 | 2020-01-02 |
Narrower conditions
Rotavirus Infections (4)
Broader conditions
Infections (4) · RNA Virus Infections (4) · Reoviridae Infections (4) · Virus Diseases (4)
Interventions
RIX4414 vaccine (3) · 13-valent pneumococcal vaccine (1) · CRM197 (non-toxic variant of diphtheria toxin) (1) · Freeze Drying (1) · Hepatitis B Vaccines (1) · Hiberix (1) · PEDIARIX (1) · Poliovirus Vaccine, Inactivated (1) · Tetanus Toxoid (1)
Sponsors
GlaxoSmithKline (3) · Limited Liability Company Pharm Aid (1)
Countries
Japan (2) · United States (2) · Costa Rica (1) · Finland (1) · Germany (1) · Russia (1) · South Korea (1) · Spain (1) · Taiwan (1)
Top investigators
Irina V. Feldblium, Dr. Sci (1)
Results publications
PMID 34788488
NIH funding
2016 (2), 2015 (1)